CARL (Carlsmed) Long-Term Debt: $15.36 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CARL Carlsmed Inc CARL
12 GF Score
Price $11.81
! 1 Warning Sign
View Full Analysis

What is Carlsmed Long-Term Debt?

Carlsmed CARL +6.68% 12 Long-Term Debt is $15.36 Mil as of Mar. 2026. GuruFocus rates CARL with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

Carlsmed's Long-Term Debt for the quarter that ended in Mar. 2026 was $15.36 Mil.

Carlsmed's quarterly Long-Term Debt declined from Sep. 2025 ($15.44 Mil) to Dec. 2025 ($15.35 Mil) but then increased from Dec. 2025 ($15.35 Mil) to Mar. 2026 ($15.36 Mil).

Carlsmed's annual Long-Term Debt increased from Dec. 2023 ($7.47 Mil) to Dec. 2024 ($15.41 Mil) but then declined from Dec. 2024 ($15.41 Mil) to Dec. 2025 ($15.35 Mil).

Carlsmed  (NAS:CARL) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Carlsmed Long-Term Debt Related Terms

Carlsmed Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Carlsmed's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Carlsmed Long-Term Debt Chart

Carlsmed Annual Data
Trend Dec23 Dec24 Dec25
Long-Term Debt
7.47 15.41 15.35

Carlsmed Quarterly Data
Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.42 15.43 15.44 15.35 15.36
CARL
12GF Score
Carlsmed Inc CARL
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $15.36 Mil mean?
Carlsmed (CARL) has a Long-Term Debt of $15.36 Mil as of Mar. 2026.
Is Carlsmed's Long-Term Debt too high?
Carlsmed's current Long-Term Debt is $15.36 Mil. Overall, Carlsmed has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Carlsmed's Long-Term Debt compare to SLP and TBRG?
Carlsmed's Long-Term Debt of $15.36 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Healthcare Providers & Services company?
A good Long-Term Debt depends on the Healthcare Providers & Services industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Carlsmed's current Long-Term Debt is $15.36 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carlsmed stock overvalued right now?
Carlsmed (CARL) has a current Long-Term Debt of $15.36 Mil. The current Long-Term Debt is $15.36 Mil. Carlsmed's overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Carlsmed (CARL), the current Long-Term Debt is $15.36 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Carlsmed Business Description

Other Exchanges I82:Germany
Address 1800 Aston Avenue, Suite 100, Carlsbad, CA, USA, 92008
Carlsmed Inc is a commercial-stage medical technology company focused on developing AI-enabled personalized solutions for spine surgery. The company operates as a single operating and reportable segment engaged in the design, manufacture, and marketing of its Aprevo technology platform, which provides customized surgical planning and implants for lumbar and cervical spine fusion procedures, mainly sold to hospitals and ambulatory surgical centers.
12GF Score

Get the complete analysis for CARL

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.81
Price